riluzole has been researched along with MPTP Neurotoxicity Syndrome in 3 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Riluzole pretreatment induced a persistent increase in dopamine turnover when compared to MPTP alone." | 1.29 | Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. ( Benazzouz, A; Boireau, A; Boraud, T; Dubédat, P; Gross, C; Stutzmann, JM, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Verhave, PS | 1 |
| Jongsma, MJ | 1 |
| Van Den Berg, RM | 1 |
| Vanwersch, RA | 1 |
| Smit, AB | 1 |
| Philippens, IH | 1 |
| Diguet, E | 1 |
| Fernagut, PO | 1 |
| Scherfler, C | 1 |
| Wenning, G | 1 |
| Tison, F | 1 |
| Benazzouz, A | 1 |
| Boraud, T | 1 |
| Dubédat, P | 1 |
| Boireau, A | 1 |
| Stutzmann, JM | 1 |
| Gross, C | 1 |
3 other studies available for riluzole and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Neuroprotective effects of riluzole in early phase Parkinson's disease on clinically relevant parameters in the marmoset MPTP model.
Topics: Animals; Callithrix; Corpus Striatum; Dopamine; Dopaminergic Neurons; Female; Male; MPTP Poisoning; | 2012 |
Effects of riluzole on combined MPTP + 3-nitropropionic acid-induced mild to moderate striatonigral degeneration in mice.
Topics: Animals; Behavior, Animal; Brain; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Motor Activi | 2005 |
Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study.
Topics: Animals; Antiparkinson Agents; Dopamine; Electromyography; Excitatory Amino Acid Antagonists; Macaca | 1995 |